Oversold

MLAB

Valuation81/ 100
Cash flow & growth69/ 100
Upside potential19/ 100
Risk potential42/ 100

MLAB's valuation is historically cheap, fundamentals are above averages, but weaker than expected earnings are holding it back, though analyst coverage is limited.

Score change since last week

The score rose 9 points, mainly due to valuation and price changes. Price fell 1.0%, from $129.09 to $127.78. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 9.2 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 152.1× versus the full-history median of 315.5× shown in the valuation table, producing 86.4/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 81.1/100. The model applies a -7.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 152.1× (18-month half-life). The favorable scenario uses 145.6× PE and $0.8 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +3%, operating margin +3.3 percentage points. Free cash flow is 22.5% of revenue. The business score is 68.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $0.84 of EPS and a 145.6× PE, suggesting about $122.00 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $146.95. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.65 of EPS and a 115.1× PE, suggesting a share price of about $74.53 — 42% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

MLAB vs Historical averages

MetricCurrentAverageRelative
PE152x329x54% lower
PE percentile225055% lower
EPS$0.84-$7.60$8.44 higher
FCF$56.1M$35.5M58% higher
Loading historical comparisons…

MLAB’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

MLAB Forward outlook

MetricOutlook
Forward valuationStrongly deteriorating
Forward earningsDecline
Forward revenueStable
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionTight

MLAB’s outlook is mixed, with weaker expected earnings weighing on the picture.

MLAB PE Valuation

Loading pe valuation table…

This table applies MLAB's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

MLAB Earnings Per Share

Loading earnings per share…

This chart tracks MLAB's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

MLAB Quarterly Revenue

Loading quarterly revenue…

This chart tracks MLAB's quarterly revenue over time and shows how sales are changing from year to year.

MLAB Free Cash Flow

Loading free cash flow…

This chart tracks MLAB's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

MLAB Total Shares

Loading shares over time…

This chart tracks changes in MLAB's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

MLAB Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

MLAB PE vs Technology Sector

Loading pe vs sector average…

This chart compares MLAB's price-to-earnings (PE) ratio with the Technology sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

MLAB Weekly Price

Loading weekly price…

This chart uses MLAB's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

MLAB Weekly Moving Averages

Loading weekly moving averages…

This chart compares MLAB's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

MLAB Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.